Phibro Animal Health Corporation (PAHC)
Automate Your Wheel Strategy on PAHC
With Tiblio's Option Bot, you can configure your own wheel strategy including PAHC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PAHC
- Rev/Share 36.1258
- Book/Share 8.1996
- PB 6.2833
- Debt/Equity 1.8161
- CurrentRatio 3.0534
- ROIC 0.1101
- MktCap 2088348517.0
- FreeCF/Share 1.1667
- PFCF 44.1614
- PE 22.6769
- Debt/Assets 0.4294
- DivYield 0.0093
- ROE 0.3081
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 3
- DCF Score 1
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | PAHC | JP Morgan | Neutral | Overweight | -- | $35 | July 7, 2025 |
| Upgrade | PAHC | BNP Paribas Exane | Underperform | Neutral | -- | $24 | June 16, 2025 |
| Initiation | PAHC | JP Morgan | -- | Neutral | -- | $22 | Sept. 10, 2024 |
News
Looking for Earnings Beat? Buy These 4 Top-Ranked Stocks
Published: February 23, 2026 by: Zacks Investment Research
Sentiment: Positive
Top-ranked stocks Revolve Group (RVLV), Phibro Animal Health (PAHC), Silicon Motion Technology (SIMO) and IPG Photonics (IPGP) are likely to beat on the bottom line in their upcoming releases.
Read More
Best Momentum Stocks to Buy for February 20th
Published: February 20, 2026 by: Zacks Investment Research
Sentiment: Positive
PAHC, CRZBY and WTI made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 20th, 2026.
Read More
4 Discounted PEG Value Stocks to Boost Your Portfolio's Health
Published: February 10, 2026 by: Zacks Investment Research
Sentiment: Positive
Discounted PEG screen highlights four value stocks, led by healthcare. One can pick Exelixis, alongside DaVita, Phibro and Allison Transmission.
Read More
3 Reasons Growth Investors Will Love Phibro (PAHC)
Published: February 06, 2026 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.
Read More
Phibro Animal Health (PAHC) is a Top-Ranked Momentum Stock: Should You Buy?
Published: February 06, 2026 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Phibro Animal Health Corporation (PAHC) Q2 2026 Earnings Call Transcript
Published: February 05, 2026 by: Seeking Alpha
Sentiment: Neutral
Phibro Animal Health Corporation (PAHC) Q2 2026 Earnings Call Transcript
Read More
4 Medical Product Stocks to Watch From a Challenging Industry (Revised)
Published: February 03, 2026 by: Zacks Investment Research
Sentiment: Negative
The Zacks Medical Products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. BSX, RMD, PAHC and BLFS reflect the favorable fundamentals.
Read More
4 Medical Product Stocks to Watch From a Challenging Industry
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Negative
The Zacks Medical products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. BSX, RMD, PAHC and BLFS reflect the favorable fundamentals.
Read More
PAHC vs. BSX: Which Stock Is the Better Value Option?
Published: January 26, 2026 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now?
Read More
Phibro (PAHC) Upgraded to Strong Buy: Here's Why
Published: January 14, 2026 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Read More
PAHC vs. BSX: Which Stock Should Value Investors Buy Now?
Published: January 09, 2026 by: Zacks Investment Research
Sentiment: Positive
Investors looking for stocks in the Medical - Products sector might want to consider either Phibro Animal Health (PAHC) or Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Best Growth Stocks to Buy for Dec. 24
Published: December 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, Dec. 24:
Read More
Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term
Published: December 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Best Growth Stocks to Buy for Dec. 22
Published: December 22, 2025 by: Zacks Investment Research
Sentiment: Positive
RNR, PAHC and DY made it to the Zacks Rank #1 (Strong Buy) growth stocks list on Dec. 22, 2025.
Read More
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock
Published: December 19, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Is Phibro Animal Health Stock a Smart Addition to Your Portfolio Now?
Published: December 16, 2025 by: Zacks Investment Research
Sentiment: Positive
PAHC rides on strong Animal Health momentum, vaccine growth and emerging market demand, even as macro and competitive risks linger.
Read More
Phibro Animal Health Stock Climbs 59.6% YTD: What's Driving It?
Published: December 10, 2025 by: Zacks Investment Research
Sentiment: Positive
PAHC's 59% YTD surge rides on strong Animal Health momentum, booming vaccines and global gains despite the rising competition.
Read More
PAHC vs. BSX: Which Stock Is the Better Value Option?
Published: December 08, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now?
Read More
3 Momentum Anomaly Stocks to Buy as Markets Gear Up for 2025 Swansong
Published: December 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Amid volatile markets, AGX, UI and PAHC show strong long-term momentum despite recent pullbacks.
Read More
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term
Published: November 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term
Published: November 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Phibro (PAHC) Upgraded to Strong Buy: Here's What You Should Know
Published: November 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
PAHC or BSX: Which Is the Better Value Stock Right Now?
Published: November 20, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
4 Stocks Trading Near 52-Week High With More Upside Potential
Published: November 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Stocks like PAHC, ATRO, COMM and HRTG are seeing price strength and have a high chance of carrying the momentum forward.
Read More
Best Momentum Stock to Buy for Nov. 20th
Published: November 20, 2025 by: Zacks Investment Research
Sentiment: Positive
PAHC, SHIP and BCAL made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 20, 2025.
Read More
Best Income Stocks to Buy for Nov. 20th
Published: November 20, 2025 by: Zacks Investment Research
Sentiment: Positive
SHIP, PAHC and FCFS made it to the Zacks Rank #1 (Strong Buy) income stocks list on November 20, 2025.
Read More
Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term
Published: November 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Phibro Animal Health Corporation (PAHC) Q1 2026 Earnings Call Transcript
Published: November 06, 2025 by: Seeking Alpha
Sentiment: Neutral
Phibro Animal Health Corporation ( PAHC ) Q1 2026 Earnings Call November 6, 2025 9:00 AM EST Company Participants Glenn David - Chief Financial Officer Jack Bendheim - Chairman, President & CEO Larry Miller - Chief Operating Officer Daniel Bendheim - Executive VP of Corporate Strategy & Director Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Ekaterina Knyazkova - JPMorgan Chase & Co, Research Division Navann Ty Dietschi - BNP Paribas, Research Division Presentation Operator Hello, and thank you for standing by. Welcome to the Phibro Animal Health Corporation First Quarter 2026 Webcast and Conference Call.
Read More
Phibro Animal Health Corporation Announces National Launch of Restoris™ Piezoelectric Dental Gel for Dogs
Published: October 30, 2025 by: Business Wire
Sentiment: Neutral
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation is proud to announce the national launch of Restoris™ piezoelectric dental gel, a revolutionary dental gel designed to treat and support long-term oral health in dogs with periodontal disease. Developed in collaboration with a leading U.S. dental school and licensed to Phibro, Restoris represents a breakthrough in veterinary dental care, offering a dual mechanism of action to restore oral health at its foundation. The launch of Re.
Read More
Is Phibro (PAHC) a Solid Growth Stock? 3 Reasons to Think "Yes"
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
About Phibro Animal Health Corporation (PAHC)
- IPO Date 2014-04-11
- Website https://www.pahc.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Jack Clifford Bendheim
- Employees 1940